Dr. Zheng co-founded OncoImmune, Inc. and served as its Chief Medical Officer since 2000. Experience: OncoC4, Inc.
OncoC4, Inc. - Cited by 18780 - Immunology - tumor immunotherapy - signal transduction - hematopoiesis
Pan ZHENG, Chief Medical Officer | Cited by 14872 | | Read 283 publications | Contact Pan ZHENG.
Pan Zheng. Information Systems, University of Canterbury. Verified email at canterbury.ac.nz - Homepage · AI applications and methodsBio-inspired ...
We are officially launching the GVN Drs. Yang Liu & Pan Zheng Academy to facilitate mentorship and training of early career virologists through formal GVN ...
Pan Zheng focuses on Immunology, Cancer research, Molecular biology, Cell biology and Cytotoxic T cell. His Immunology research is multidisciplinary, relying on ...
Pan Zheng, MD, Ph.D. AIMBE College of Fellows Class of 2022. For outstanding contributions to immune checkpoint regulation and drug development in cancer ...